Federated Hermes, Inc. Seres Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

  • $41.2 Billion
  • Q2 2024

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
SELL
$2.33 - $5.07 $5.62 Million - $12.2 Million
-2,413,084 Reduced 21.18%
8,981,717 $21.4 Million
Q2 2023

Aug 14, 2023
SELL
$4.67 - $6.55 $18.1 Million - $25.4 Million
-3,882,555 Reduced 25.41%
11,394,801 $54.6 Million
Q1 2023

May 08, 2023
SELL
$4.95 - $6.09 $13.9 Million - $17.1 Million
-2,808,582 Reduced 15.53%
15,277,356 $86.6 Million
Q4 2022

Feb 13, 2023
SELL
$5.09 - $9.05 $2.1 Million - $3.74 Million
-413,198 Reduced 2.23%
18,085,938 $101 Million
Q3 2022

Nov 14, 2022
BUY
$3.5 - $7.2 $1.81 Million - $3.72 Million
516,880 Added 2.87%
18,499,136 $119 Million
Q2 2022

Aug 15, 2022
BUY
$2.7 - $7.62 $26.9 Million - $76 Million
9,971,450 Added 124.47%
17,982,256 $61.7 Million
Q1 2022

May 13, 2022
BUY
$6.3 - $8.84 $6.91 Million - $9.69 Million
1,096,670 Added 15.86%
8,010,806 $57 Million
Q4 2021

Feb 14, 2022
SELL
$6.02 - $11.43 $1.61 Million - $3.06 Million
-267,964 Reduced 3.73%
6,914,136 $57.6 Million
Q3 2021

Nov 15, 2021
BUY
$5.46 - $22.6 $26.4 Million - $109 Million
4,834,191 Added 205.89%
7,182,100 $50 Million
Q2 2021

Aug 16, 2021
SELL
$18.46 - $24.36 $7.66 Million - $10.1 Million
-415,000 Reduced 15.02%
2,347,909 $56 Million
Q1 2021

May 13, 2021
SELL
$17.66 - $28.92 $3.36 Million - $5.5 Million
-190,161 Reduced 6.44%
2,762,909 $56.9 Million
Q4 2020

Feb 12, 2021
BUY
$23.25 - $37.73 $3.8 Million - $6.17 Million
163,403 Added 5.86%
2,953,070 $72.4 Million
Q3 2020

Nov 12, 2020
BUY
$3.74 - $28.74 $6.59 Million - $50.6 Million
1,760,867 Added 171.16%
2,789,667 $79 Million
Q1 2020

May 13, 2020
BUY
$2.64 - $3.82 $1.67 Million - $2.42 Million
633,135 Added 160.02%
1,028,800 $3.67 Million
Q4 2019

Feb 14, 2020
SELL
$2.99 - $4.42 $52,193 - $77,155
-17,456 Reduced 4.23%
395,665 $1.37 Million
Q3 2019

Nov 14, 2019
BUY
$2.29 - $4.16 $941,680 - $1.71 Million
411,214 Added 21563.4%
413,121 $1.66 Million
Q2 2019

Aug 14, 2019
SELL
$2.28 - $7.35 $2,250 - $7,254
-987 Reduced 34.11%
1,907 $6,000
Q1 2019

May 10, 2019
SELL
$4.83 - $7.21 $8.39 Million - $12.5 Million
-1,736,334 Reduced 99.83%
2,894 $20,000
Q4 2018

Feb 13, 2019
SELL
$4.52 - $8.88 $140,242 - $275,519
-31,027 Reduced 1.75%
1,739,228 $7.86 Million
Q3 2018

Nov 13, 2018
BUY
$7.33 - $9.23 $3,049 - $3,839
416 Added 0.02%
1,770,255 $13.4 Million
Q2 2018

Aug 10, 2018
BUY
$6.91 - $9.55 $21,821 - $30,158
3,158 Added 0.18%
1,769,839 $15.2 Million
Q1 2018

May 09, 2018
BUY
$7.34 - $11.16 $1.98 Million - $3.02 Million
270,224 Added 18.06%
1,766,681 $13 Million
Q4 2017

Feb 14, 2018
BUY
$9.15 - $12.64 $6.56 Million - $9.07 Million
717,451 Added 92.1%
1,496,457 $0
Q3 2017

Nov 13, 2017
BUY
$12.81 - $16.85 $9.98 Million - $13.1 Million
779,006
779,006 $12.5 Million

Others Institutions Holding MCRB

# of Institutions
93
Shares Held
46.7M
Call Options Held
119K
Put Options Held
466K
View Full List

About Seres Therapeutics, Inc.

MCRB Quotes by TradingView
  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $102M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email